SK pharmteco

SK pharmteco, a strategic portfolio company of South Korea's SK Inc., operates within the pharmaceutical sector, focusing on advanced manufacturing and development. Its facility in Dublin, Ireland, known as Swords Campus (SK biotek Ireland), boasts nearly 60 years of experience in manufacturing Active Pharmaceutical Ingredients (APIs) and intermediates. For over three decades, this campus has led in the development, scale-up, and commercial production of highly potent chemical intermediates and APIs, establishing a strong reputation for specialized pharmaceutical services. The company's operations are underpinned by a commitment to innovation and quality in drug substance manufacturing.

Swords Campus is equipped with multi-scale plants capable of handling production from grams to hundreds of kilograms, specifically designed for materials with an Occupational Exposure Limit (OEL) as low as 10 ng/m³. This integrated facility seamlessly combines manufacturing plants with R&D and Quality Control laboratories within a single building, fostering efficiency and collaboration. SK pharmteco emphasizes robust safety compliance and adherence to high-quality standards, ensuring it remains a reliable supplier of High Potency APIs (HPAPIs) to a diverse clientele. Understanding the expertise behind these operations is key, and you can Meet SK pharmteco's team to learn more about their dedicated professionals.

With a revenue of $675.1M and an employee range of 1,000-5,000 individuals, SK pharmteco positions itself as a significant player in the global pharmaceutical contract manufacturing market. The company's proven track record as a trusted supplier of HPAPIs to multiple customers highlights its operational excellence and dedication to meeting stringent industry requirements. SK pharmteco's strategic integration withinView more...